OCSL carries meaningful sell-side coverage, yet that coverage does not point to a sizable upside objective. Roughly six firms maintain current targets: J.P. Morgan at $10.50 (cut from $13.50 in March 2026), Wells Fargo at $12, Oppenheimer and B. Riley Securities each at $13, Lucid Capital at $13.75, and KBW at $14. The arithmetic mean of these targets sits near $12.50, or only about 5% above the recent price — well short of the 10% threshold needed for a meaningful central target. Even the average of the targets above the current price rounds to roughly $13.
Because no usable analyst aggregate clears that bar, the $14 figure serves as a fallback target drawn from public discussion. It aligns with three identifiable reference points: the stock's 52-week high near $13.91, the top of the analyst range (KBW's $14), and a partial — not full — narrowing of the discount to NAV of $15.63 per share reported for the quarter ended September 30, 2026. It is a scenario discussed publicly, not a prediction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At roughly $11.85, OCSL trades well below its book value. Reaching $14 implies an approximately 18% gain, a substantial move for a BDC that has spent much of the past year drifting lower within a $10.63-to-$13.91 range. The path would most plausibly run through a re-rating tied to confidence that dividend coverage and credit quality have stabilized, allowing the discount to NAV to narrow toward the levels implied by the more constructive analyst targets.
OCSL reported NAV of $15.63 per share as of September 30, 2026, meaning the stock carries a deep discount of roughly 24% to net assets. Non-accrual investments have fallen to about 1.8% of the debt portfolio, down from roughly 3.2% a year earlier, and first-lien senior secured loans make up the large majority of the portfolio. Weighted average yields on new investments have improved, and management has maintained conservative leverage. Any sustained improvement in credit quality or a recovery in software-sector valuations could support a narrower discount to NAV.
The company cut its quarterly dividend from $0.40 to roughly $0.33 per share during fiscal 2026, and forward payouts of about $1.32 imply a yield near 11%. Analysts have repeatedly trimmed price targets, reflecting concern about dividend coverage and markdowns in software and AI-exposed loans — Pluralsight was cited as a major detractor. All six covering firms rate the stock a Hold or equivalent, with none issuing a Buy. Continued unrealized depreciation, renewed non-accruals, or pressure from lower reference rates on floating-rate income could keep the discount to NAV wide.
The stock has visible structure: support near the 52-week low around $10.63, resistance at the prior 52-week high near $13.91, and a fundamental anchor at NAV of $15.63. A move toward $14 would require clearing the 52-week high, effectively a breakout above the upper bound of the recent trading range, while still leaving the shares at a modest discount to book value.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms differ in their assumptions. The most important items to watch are quarterly net investment income (NII) per share and dividend coverage, movements in NAV, non-accrual trends, software and technology-sector valuations, and the refinancing of the $350 million of unsecured notes maturing in January 2027. Changes in short-term interest rates and credit spreads also matter, given the portfolio's floating-rate exposure. From what I see, monitoring these closely helps clarify whether the discount can narrow.
I rely on Tickeron's AI Daily Buy/Sell Signals as part of my regular review process. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and data-driven analysis. It helps me track momentum and potential turning points efficiently when following names like OCSL alongside traditional fundamental work.
The $14 target is a fallback objective, not a published analyst consensus. It corresponds to the stock's 52-week high area and a partial recovery toward NAV, implying an 18% gain from roughly $11.85. The case for the move rests on narrowing the deep discount to book value as credit quality stabilizes; the case against it rests on a reduced dividend, cautious analyst ratings, and lingering software-sector markdowns. Investors should monitor dividend coverage, NAV, non-accruals, and rate movements before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for OCSL moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In 14 of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at 61%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OCSL as a result. In 40 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
The Moving Average Convergence Divergence Histogram (MACD) for OCSL turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 18 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
OCSL moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCSL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
The Aroon Indicator for OCSL entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for OCSL crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 38%.
Following a +2.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where OCSL advanced for three days, in 115 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.
OCSL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. OCSL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.796) is normal, around the industry mean (2.423). P/E Ratio (26.042) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (1.318). Dividend Yield (0.106) settles around the average of (0.274) among similar stocks. P/S Ratio (20.450) is also within normal values, averaging (15.906).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCSL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a private equity fund
Industry InvestmentManagers